"10.1371_journal.pone.0122121","plos one","2015-04-07T00:00:00Z","Motomu Hashimoto; Toru Yamazaki; Masahide Hamaguchi; Takeshi Morimoto; Masashi Yamori; Keita Asai; Yu Isobe; Moritoshi Furu; Hiromu Ito; Takao Fujii; Chikashi Terao; Masato Mori; Takashi Matsuo; Hiroyuki Yoshitomi; Keiichi Yamamoto; Wataru Yamamoto; Kazuhisa Bessho; Tsuneyo Mimori","Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Oral and Maxillofacial Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Endocrinology and Metabolism, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; Division of General Medicine, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan; Department of Orthopedic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Clinical Epidemiology and Biostatistics, Graduate School of Medicine, Osaka University, Osaka, Japan; Department of Health Information Management, Kurashiki Sweet Hospital, Kurashiki, Japan","Conceived and designed the experiments: M. Hashimoto TY M. Hamaguchi T. Morimoto. Analyzed the data: M. Hashimoto TY M. Hamaguchi T. Morimoto CT. Wrote the paper: M. Hashimoto TY M. Hamaguchi T. Morimoto TF T. Mimori. Contributed to preparing the data on arthritis: M. Hashimoto MF HI TF HY T. Mimori. Contributed to preparing the data on periodontitis: TY MY KA YI KB. Performed the PCR experiments: M. Hashimoto MM T. Matsuo. Contributed to building the database: CT KY WY.","M. Hashimoto TF, MF, HI, and T. Mimori are affiliated with a department that is supported financially by five pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Bristol-Myers K.K., Chugai Pharmaceutical Co., Ltd., AbbVie GK., Eisai Co., Ltd.). M. Hashimoto and MF have received grant and research support from Astellas Pharma Inc. and Pfizer Japan Inc. HI has received grant and research support from Astellas Pharma Inc., Pfizer Japan Inc., NTT communications, and Takeda Pharmaceutical Co., Ltd. TF has received grant and research support from Takeda Pharmaceutical Co., Santen Pharmaceutical Co., Ltd., Astellas Pharma Inc., Asahi Kasei Pharma Corporation, and Daiichi Sankyo Co., Ltd. T. Mimori has received grant and research support from Asahi Kasei Pharma Corporation, Astellas Pharma Inc., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., Santen Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd., and speakers bureau from AbbVie GK., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., and Takeda Pharmaceutical Co., Ltd.; the sponsors were not involved in the study design; in the collection, analysis, interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","04","Motomu Hashimoto","MH",18,TRUE,1,1,1,1,TRUE,TRUE,TRUE,3,"9;10;14",TRUE
